Treatment Registry
TR-0593 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Next Vial · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$249.97

Medication · Starting price (shared listing with semaglutide, not broken out by drug)$249.97

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price (shared listing with semaglutide, not broken out by drug)

Doctor-Led Weight Loss Plans as Low as $249.97/Month Provider personalized dosages, one all-in price.

source

Per month$249.97Charged today$249.97
Visit Next Vial

We earn nothing from this link. Next Vial has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyManifest Pharmacy, Greer SC
StatesAll states except Alaska
PrescriberBoth
Cancellation“Login to your Next Vial account and reorder or cancel at any time. You will be contacted before your medication is to be refilled and billed to your credit card.”

Not yet checked: membership and consult fee.

Recorded from nextvial.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The single product page has a medication selector toggling between 'Semaglutide Injection' and 'Tirzepatide Injection' but only ever displays one shared starting price ($249.97/mo) rather than a price for each drug separately, so the same figure was recorded for both with a note in the label. The FAQ's 'Next Vial currently serves patients in the following states:' sentence is followed by what is evidently a dynamic list/map widget that never rendered as text, so no actual state list could be read. 'No Membership' is stated explicitly on the homepage.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0593
Readings
1

Related records

What else Next Vial sells

All Next Vial programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Next Vial compounded tirzepatide (TR-0593). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0593

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.